You searched for "foundation"

2524 results found

Brolucizumab in age-related macular degeneration, HAWK Study

The aim of the study was to collect additional data on efficacy and safety of brolucizumab 6mg intended for commercialization in age-related macular degeneration (AMD) (with an increase in pH and decrease in polysorbate concentration). The HAWK Study was a...

Ocular electrophysiology

A 34-year-old woman, who is a CEO in a multinational firm, has been losing vision over the last 12 months. She has seen her opticians, who initially tried different glasses but could not improve things. Clinical examination is unremarkable. How...

Zeiss Forum

The tech column this issue reports on the features and experience of using the Zeiss Forum software. I have overseen the installation, troubleshooting, training and use of the software over the last two years. As both a consultant specialising in...

Practical Handbook of OCT (Retina, Choroid, Glaucoma)

With the rapid development and expansion in the usage of optical coherence tomography (OCT) technology there is always demand for a new OCT publication on the bookshelves. The operation and acquisition skills required are more easily acquired than for the...

Internuclear ophthalmoplegia: a case study

A 44-year-old patient presents with binocular, mostly horizontal diplopia when fixating on moving objects. This has been ongoing for approximately five years. He is known to have multiple sclerosis and had an episode of optic neuritis six years prior in...

In conversation with Marc Labetoulle

Following the hugely successful 10th Tear Film & Ocular Surface Society (TFOS) 2024 Conference which took place in Venice, Italy between 30 October – 2 November, we managed to have a quick Q&A with presenting attendee, Marc Labetoulle. Delivering his...

Contemporary glaucoma therapy: spoilt for choice

The goal of glaucoma management is to prevent visual loss and disease progression in the patient’s lifetime through effective lowering of intraocular pressure (IOP), the primary modifiable risk factor in glaucoma. Sustained and consistent IOP reduction is key to halting...

Screening for stroke-related visual problems

The aim was to report the initial development and evaluation of a suitable screening tool for detecting visual problems after stroke. The tool has four components. The first three include questions asked by examiners about patients’ ocular history and symptoms,...

What’s new in glaucoma? Clinical trials drive practice changes, surgical advancements gather pace

Rod McNeil reviews the latest developments in the treatment of glaucoma in the UK. Primary open-angle glaucoma (POAG), which accounts for over two-thirds of all glaucoma cases, has an estimated UK prevalence in 2017 of approximately 2% of people over...

What’s new in wet AMD papers?

Paper presentations on neovascular (‘wet’) age-related macular degeneration (AMD) from the 16th European Society of Retina Specialists Congress, Copenhagen, September 2016, outline recent research directions evaluating the impact of vision loss on key health domains, patient preferences in the process...

What's trending Feb/Mar 2023

A round-up of the eye related hot topics that have been trending on social media over the last few weeks. #nativity #needleeye Happy New Year! Let’s kick things off with a holiday-related story. Birmingham-based micro-engraver Graham Short engraved by hand...

Vision measurements vs. self-rating

The aim of this study was to evaluate the association between self-rated vision status and tests of visual acuity, contrast sensitivity, stereoacuity, bilateral visual field and self-reported visual function in specific domains of near and far vision. The goal was...